GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.8139
-0.1062 (-11.54%)
At close: Dec 30, 2025, 4:00 PM EST
0.8280
+0.0141 (1.73%)
After-hours: Dec 30, 2025, 7:49 PM EST
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $8.66 million as of December 30, 2025. Its market cap has increased by 37.41% in one year.
Market Cap
8.66M
Enterprise Value
6.13M
1-Year Change
37.41%
Ranking
Category
Stock Price
$0.81
Market Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $8.66M, a decrease of -89.60%. That is a compound annual growth rate of -25.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 9.80M | 44.12% |
| Dec 31, 2024 | 6.80M | -35.85% |
| Dec 29, 2023 | 10.60M | -63.19% |
| Dec 30, 2022 | 28.80M | -69.13% |
| Dec 31, 2021 | 93.30M | 181.02% |
| Dec 31, 2020 | 33.20M | 503.64% |
| Dec 31, 2019 | 5.50M | -83.13% |
| Dec 31, 2018 | 32.60M | -60.82% |
| Mar 27, 2018 | 83.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.87B |
| Johnson & Johnson | 500.07B |
| AbbVie | 407.98B |
| UnitedHealth Group | 297.97B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 264.63B |
| Novo Nordisk | 229.27B |